elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q30608529-3ACD2D08-88EB-4AEA-B3CC-77A10AEE6957
Q30608529-3ACD2D08-88EB-4AEA-B3CC-77A10AEE6957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30608529-3ACD2D08-88EB-4AEA-B3CC-77A10AEE6957
The comparison of trial data-based and registry data-based cost-effectiveness of infliximab treatment for rheumatoid arthritis in Sweden using a modeling approach.
P50
Q30608529-3ACD2D08-88EB-4AEA-B3CC-77A10AEE6957
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30608529-3ACD2D08-88EB-4AEA-B3CC-77A10AEE6957
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9a8c5e51ef46939c00886bd8409357b552f7dc3c
P1545
5
http://www.w3.org/2001/XMLSchema#string
P1932
Ronald van Vollenhoven
http://www.w3.org/2001/XMLSchema#string
P50
Ronald van Vollenhoven